Open access · CC-BY
via OpenAlex
Fisetin Supplementation Attenuates Premature Vascular Aging Induced by Doxorubicin via Suppression of Cellular Senescence and Mitochondrial Oxidative Stress
Mary A. Darrah, Sophia A. Mahoney, Ravinandan Venkatasubramanian, Nicholas S. VanDongen, Katelyn R. Ludwig, Douglas R. Seals, Matthew J. Rossman, Zachary S. Clayton
Aging Cell · 2026 · ▲ 1 citations
Mitochondrial dysfunction
Cellular senescence
Senolytics
Cell culture / in vitro
Human
Mouse
In vitro
Abstract
The genotoxic agent doxorubicin induces premature vascular aging, defined by vascular endothelial dysfunction and aortic stiffening. Excess vascular cell senescence(definition) and the accompanying senescence-associated secretory phenotype (SASP) are key mechanisms underlying doxorubicin-induced vascular dysfunction, in part, by promoting excess mitochondrial oxidative stress, which reduces the bioavailability of the vasodilatory molecule nitric oxide (NO). In the present study, we assessed if the natural senolytic fisetin mitigates doxorubicin-induced cellular senescence and the SASP to improve vascular function following doxorubicin administration and explored the underlying mechanisms. Young adult (6 months) mice were treated with doxorubicin, followed by oral, intermittent fisetin supplementation (100 mg/kg/day; 1 week on treatment-2 weeks off treatment-1 week on treatment). Vascular endothelial function, aortic stiffness, cellular senescence markers, SASP expression, NO bioavailability, and mitochondrial oxidative stress were assessed. Parallel experiments in human aortic endothelial cells were conducted to provide further mechanistic insight. Fisetin mitigated excess vascular cell senescence and the SASP in young mice administered doxorubicin and reversed doxorubicin-induced endothelial dysfunction (p < 0.001) and aortic stiffening (p < 0.001), in part through suppression of excess cellular senescence, higher NO bioavailability, and lower mitochondrial oxidative stress. Modulation of the circulating SASP (plasma) also contributed to the observed vascular improvements with fisetin. In vitro, fisetin reduced cellular senescence in doxorubicin-exposed endothelial cells, supporting isolated artery and in vivo observations. These findings identify oral intermittent fisetin supplementation as a promising therapeutic strategy for targeting excess cellular senescence to improve vascular function in settings of premature vascular aging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/acel.70535
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Darrah, M.A., Mahoney, S.A., Venkatasubramanian, R., VanDongen, N.S., Ludwig, K.R., Seals, D.R., Rossman, M.J., & Clayton, Z.S. (2026). Fisetin Supplementation Attenuates Premature Vascular Aging Induced by Doxorubicin via Suppression of Cellular Senescence and Mitochondrial Oxidative Stress. <em>Aging Cell</em>. https://doi.org/10.1111/acel.70535
Vancouver
Darrah MA, Mahoney SA, Venkatasubramanian R, VanDongen NS, Ludwig KR, Seals DR, et al. Fisetin Supplementation Attenuates Premature Vascular Aging Induced by Doxorubicin via Suppression of Cellular Senescence and Mitochondrial Oxidative Stress. Aging Cell. 2026. doi:10.1111/acel.70535.
BibTeX
@article{mary2026Fiseti,
title = {Fisetin Supplementation Attenuates Premature Vascular Aging Induced by Doxorubicin via Suppression of Cellular Senescence and Mitochondrial Oxidative Stress},
author = {Mary A. Darrah and Sophia A. Mahoney and Ravinandan Venkatasubramanian and Nicholas S. VanDongen and Katelyn R. Ludwig and Douglas R. Seals and Matthew J. Rossman and Zachary S. Clayton},
journal = {Aging Cell},
year = {2026},
doi = {10.1111/acel.70535},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging cell 2026
Open access · OA
Fisetin Supplementation Attenuates Premature Vascular Aging Induced by Doxorubicin via Suppression of Cellular Senescence and Mitochondrial Oxidative Stress.
bioRxiv (Cold Spring Harbor Laboratory) 2025
Preprint · CC-BY
Senolytic treatment with fisetin reverses age-related endothelial dysfunction partially mediated by SASP factor CXCL12
CU Scholar (University of Colorado Boulder) 2025
Preprint
The Role of Cellular Senescence and the Senescence-Associated Secretory Phenotype in Vascular Aging: Amelioration by the Natural Senolytic Fisetin
Aging Cell 2023
Open access · CC-BY
Intermittent supplementation with fisetin improves arterial function in old mice by decreasing cellular senescence
Aging cell 2026
Open access · OA
Senolytic Treatment With Fisetin Reverses Age-Related Endothelial Dysfunction Partially Mediated by SASP Factor CXCL12.
Hypertension 2023
Preprint · OA